May require fee or membership

Identifies clinical trials on medication-assisted treatment for alcohol use disorder from ClinicalTrials.gov, finding that 12.6% involving pharmaceutical treatment were prematurely terminated and 39.1% had not published results

Describes prevention strategies for the identification of unhealthy alcohol use in primary care, including outlining risk factors, methods of screening, and a model for how to adapt alcohol-related prevention methods to a stepped care approach

Aims to determine the proportion and characteristics of adults in primary care who screen positive for unhealthy substance use one or more years after screening negative

This study evaluates the test-retest reliability of a patient-report Alcohol Symptom Checklist questionnaire when it is used in routine care, including primary care and mental health specialty settings, suggesting that the Alcohol Symptom Checklist may be a valuable tool in supporting treatment and care of patients with alcohol use disorder

Examines the impact of implementation of an Alcohol Symptom Checklist in identifying primary care patients with alcohol use disorder, finding that checklists can be helpful with diagnosis and treatment

Systematically reviews 156 trials, finding the best evidence of effectiveness for acamprosate, disulfiram, baclofen, and oral naltrexone among patients with alcohol use disorder supporting the expanded use of these medications in the clinical setting

A review of the literature on clinical trials on pharmacotherapies for alcohol use disorder, noting that topiramate and gabapentin have been used and that baclofen and nalmefene have been approved in some other countries

Describes the integration of SBIRT into the electronic health record to 1) inform clinical intervention and 2) measure the prevalence of substance use throughout pregnancy

Study exploring implementation of a protocol in the emergency department where patients who were discharged with alcohol use disorder received naltrexone and support for substance use

Describes the experience of continuing the validation of the Practice Integration Profile measure using internal consistency, intra-rater consistency, and inter-rater consistency with a separate and larger sample from a broader array of practices